<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36358582</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2211</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox11112211</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus was first recognized in late 2019 and remains a significant threat. We therefore assessed the use of local methylene blue photodynamic viral inactivation (MB-PDI) in the oral and nasal cavities, in combination with the systemic anti-viral, anti-inflammatory and antioxidant actions of orally ingested methylene blue (MB) and photobiomodulation (PBM) for COVID-19 disease. The proposed protocol leverages the separate and combined effects of MB and 660nm red light emitted diode (LED) to comprehensively address the pathophysiological sequelae of COVID-19. A total of eight pilot subjects with COVID-19 disease were treated in the Bahamas over the period June 2021-August 2021, using a remote care program that was developed for this purpose. Although not a pre-requisite for inclusion, none of the subjects had received any COVID-19 vaccination prior to commencing the study. Clinical outcome assessment tools included serial cycle threshold measurements as a surrogate estimate of viral load; serial online questionnaires to document symptom response and adverse effects; and a one-year follow-up survey to assess long-term outcomes. All subjects received MB-PDI to target the main sites of viral entry in the nose and mouth. This was the central component of the treatment protocol with the addition of orally ingested MB and/or PBM based on clinical requirements. The mucosal surfaces were irradiated with 660 nm LED in a continuous emission mode at energy density of 49 J/cm<sup>2</sup> for PDI and 4.9 J/cm<sup>2</sup> for PBM. Although our pilot subjects had significant co-morbidities, extremely high viral loads and moderately severe symptoms during the Delta phase of the pandemic, the response to treatment was highly encouraging. Rapid reductions in viral loads were observed and negative PCR tests were documented within a median of 4 days. These laboratory findings occurred in parallel with significant clinical improvement, mostly within 12-24 h of commencing the treatment protocol. There were no significant adverse effects and none of the subjects who completed the protocol required in-patient hospitalization. The outcomes were similarly encouraging at one-year follow-up with virtual absence of "long COVID" symptoms or of COVID-19 re-infection. Our results indicate that the protocols may be a safe and promising approach to challenging COVID-19 disease. Moreover, due its broad spectrum of activity, this approach has the potential to address the prevailing and future COVID-19 variants and other infections transmitted via the upper respiratory tract. Extensive studies with a large cohort are warranted to validate our results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hepburn</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0488-2525</Identifier><AffiliationInfo><Affiliation>Luminnova Health, 34 Harbour Bay Plaza, East Bay Street, Nassau P.O. Box N-1081, Bahamas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams-Lockhart</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chief Medical Officer, Capriata Health and Wellness, Nassau P.O. Box N-9792, Bahamas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bensadoun</LastName><ForeName>Ren&#xe9; Jean</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0003-1290-7497</Identifier><AffiliationInfo><Affiliation>Centre De Haute Energie, Department of Oncology Radiology, 10 Boulevard Pasteur, 06000 Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanna</LastName><ForeName>Reem</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2882-2156</Identifier><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, Laser Therapy Centre, University of Genoa, Vaile Benedetto XV, 6, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Restorative Dental Sciences, UCL-Eastman Dental Institute, Faculty of Medical Sciences, Rockefeller Building, London WC1E 6DE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral Surgery, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">SARS CoV-2 genes expression</Keyword><Keyword MajorTopicYN="N">light emitted diodes</Keyword><Keyword MajorTopicYN="N">oral methylene blue</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">photobiomodulation</Keyword><Keyword MajorTopicYN="N">photodynamic inactivation</Keyword><Keyword MajorTopicYN="N">photooxidants</Keyword><Keyword MajorTopicYN="N">viral load</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. Juliette Hepburn customized the LED treatment device and modified the treatment protocol originally developed by Detlef Schikora. Juliette Hepburn is the Medical Director of Luminnova Health which filed an international patent along with Detlef Schikora for the treatment protocols outlined.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36358582</ArticleId><ArticleId IdType="pmc">PMC9686966</ArticleId><ArticleId IdType="doi">10.3390/antiox11112211</ArticleId><ArticleId IdType="pii">antiox11112211</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang L., Li Q., Liang Z., Li T., Liu S., Cui Q., Nie J., Wu Q., Qu X., Huang W., et al. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg. Microbes. Infect. 2022;11:1&#x2013;5. doi: 10.1080/22221751.2021.2017757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2017757</ArticleId><ArticleId IdType="pmc">PMC8725892</ArticleId><ArticleId IdType="pubmed">34890524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilaberte Y., Rezusta A., Juarranz A., Hamblin M.R. Editorial: Antimicrobial Photodynamic Therapy: A New Paradigm in the Fight Against Infections. Front. Med. 2021;8:788888. doi: 10.3389/fmed.2021.788888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.788888</ArticleId><ArticleId IdType="pmc">PMC8586065</ArticleId><ArticleId IdType="pubmed">34778330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., S&#x103;l&#x103;gean T., Bordea I.R., Benedicenti S. Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review. Antioxidants. 2020;9:875. doi: 10.3390/antiox9090875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090875</ArticleId><ArticleId IdType="pmc">PMC7555229</ArticleId><ArticleId IdType="pubmed">32947974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghahestani S.M., Shahab E., Karimi S., Madani M.H. Methylene blue may have a role in the treatment of COVID-19. Med. Hypotheses. 2020;144:110163. doi: 10.1016/j.mehy.2020.110163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110163</ArticleId><ArticleId IdType="pmc">PMC7409924</ArticleId><ArticleId IdType="pubmed">33254484</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabholkar N., Gorantla S., Dubey S.K., Alexander A., Taliyan R., Singhvi G. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations. Biomed. Pharmacother. 2021;142:112023. doi: 10.1016/j.biopha.2021.112023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112023</ArticleId><ArticleId IdType="pmc">PMC8352658</ArticleId><ArticleId IdType="pubmed">34399199</ArticleId></ArticleIdList></Reference><Reference><Citation>Duicu O.M., Privistirescu A., Wolf A., Petru&#x15f; A., D&#x103;nil&#x103; M.D., Ra&#x163;iu C.D., Muntean D.M., Sturza A. Methylene blue improves mitochondrial respiration and decreases oxidative stress in a substrate-dependent manner in diabetic rat hearts. Can. J. Physiol. Pharmacol. 2017;95:1376&#x2013;1382. doi: 10.1139/cjpp-2017-0074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2017-0074</ArticleId><ArticleId IdType="pubmed">28738167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker D., Lu Y., Zhang Q. From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue. Mol. Neurobiol. 2018;55:5137&#x2013;5153. doi: 10.1007/s12035-017-0712-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0712-2</ArticleId><ArticleId IdType="pmc">PMC5826781</ArticleId><ArticleId IdType="pubmed">28840449</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J.C., Bruchey A.K., Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog. Neurobiol. 2012;96:32&#x2013;45. doi: 10.1016/j.pneurobio.2011.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.10.007</ArticleId><ArticleId IdType="pmc">PMC3265679</ArticleId><ArticleId IdType="pubmed">22067440</ArticleId></ArticleIdList></Reference><Reference><Citation>Auchter A., Williams J., Barksdale B., Monfils M.H., Gonzalez-Lima F. Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion. J. Alzheimers Dis. 2014;42:S525&#x2013;S535. doi: 10.3233/JAD-141527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141527</ArticleId><ArticleId IdType="pubmed">25079810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang S.T., Papp H., Kuczmog A., Eells R., Condor Capcha J.M., Shehadeh L.A., Jakab F., Buchwald P. Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19. Pharmaceuticals. 2022;15:621. doi: 10.3390/ph15050621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15050621</ArticleId><ArticleId IdType="pmc">PMC9144480</ArticleId><ArticleId IdType="pubmed">35631447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V., Medaglia C., Cerny A., Tapparel C. Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro. Sci. Rep. 2021;11:14295. doi: 10.1038/s41598-021-92481-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92481-9</ArticleId><ArticleId IdType="pmc">PMC8275569</ArticleId><ArticleId IdType="pubmed">34253743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H., Kang S.G., Yoon S.I., Ko H.J., Kim P.H., Hong E.J., An B.S., Lee E., Lee G.S. Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation. Sci. Rep. 2017;7:2409. doi: 10.1038/s41598-017-12635-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12635-6</ArticleId><ArticleId IdType="pmc">PMC5622101</ArticleId><ArticleId IdType="pubmed">28963531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kast R.E. Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia. Front. Oncol. 2018;8:280. doi: 10.3389/fonc.2018.00280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00280</ArticleId><ArticleId IdType="pmc">PMC6072867</ArticleId><ArticleId IdType="pubmed">30101125</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;sche W., Bosia A., Heller R., Pescarmona G.P., Arese P., Till U. Methylene blue inhibits the arachidonic acid metabolism in human blood platelets. Biomed. Biochim. Acta. 1988;47:S100-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3248097</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough P.A., Alexander P.E., Armstrong R., Arvinte C., Bain A.F., Bartlett R.P., Berkowitz R.L., Berry A.C., Borody T.J., Brewer J.H., et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) Rev. Cardiovasc. Med. 2020;21:517&#x2013;530. doi: 10.31083/j.rcm.2020.04.264.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2020.04.264</ArticleId><ArticleId IdType="pubmed">33387997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojadzic D., Alcazar O., Buchwald P. Methylene blue inhibits the SARS-CoV-2 spike&#x2013;ACE2 protein-protein interaction&#x2013;a mechanism that can contribute to its antiviral activity against COVID-19. Front. Pharmacol. 2020;11:600372. doi: 10.3389/fphar.2020.600372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.600372</ArticleId><ArticleId IdType="pmc">PMC7838506</ArticleId><ArticleId IdType="pubmed">33519460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura A., Ohnishi S. Uncoating of Influenza Virus in Endosomes. J. Virol. 1984;51:497&#x2013;504. doi: 10.1128/jvi.51.2.497-504.1984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.51.2.497-504.1984</ArticleId><ArticleId IdType="pmc">PMC254465</ArticleId><ArticleId IdType="pubmed">6431119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorshkov K., Chen C.Z., Bostwick R., Rasmussen L., Tran B.N., Cheng Y.S., Xu M., Pradhan M., Henderson M., Zhu W., et al. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect. Dis. 2021;7:1389&#x2013;1408. doi: 10.1021/acsinfecdis.0c00349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00349</ArticleId><ArticleId IdType="pmc">PMC7771250</ArticleId><ArticleId IdType="pubmed">33346633</ArticleId></ArticleIdList></Reference><Reference><Citation>te Velthuis A.J., van den Worm S.H., Sims A.C., Baric R.S., Snijder E.J., van Hemert M.J. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6:e1001176. doi: 10.1371/journal.ppat.1001176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001176</ArticleId><ArticleId IdType="pmc">PMC2973827</ArticleId><ArticleId IdType="pubmed">21079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenn A.M., Skendelas J.P., Moussa D.N., Muccigrosso M.M., Popovich P.G., Lifshitz J., Eiferman D.S., Godbout J.P. Methylene Blue Attenuates Traumatic Brain Injury-Associated Neuroinflammation and Acute Depressive-Like Behavior in Mice. J. Neurotrauma. 2015;32:127&#x2013;138. doi: 10.1089/neu.2014.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2014.3514</ArticleId><ArticleId IdType="pmc">PMC4291210</ArticleId><ArticleId IdType="pubmed">25070744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi-Hang L., Si-Yuan W., Li-Li C., Jia-Yuan Z., Qing-Feng K., Dan-Rui X., Wen-Ping L. Methylene Blue Mitigates Acute Neuroinflammation after Spinal Cord Injury through Inhibiting NLRP3 Inflammasome Activation in Microglia. Front. Cell. Neurosci. 2017;11:391. doi: 10.3389/fncel.2017.00391.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00391</ArticleId><ArticleId IdType="pmc">PMC5732444</ArticleId><ArticleId IdType="pubmed">29311826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao J., Zhang H., Yu J., Chen X., Yang L. Methylene Blue Attenuates Diabetic Retinopathy by Inhibiting NLRP3 Inflammasome Activation in STZ-Induced Diabetic Rats. Ocul. Immunol. Inflamm. 2019;27:836&#x2013;843. doi: 10.1080/09273948.2018.1450516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2018.1450516</ArticleId><ArticleId IdType="pubmed">29608341</ArticleId></ArticleIdList></Reference><Reference><Citation>Thesnaar L., Bezuidenhout J.J., Petzer A., Petzer J.P., Cloete T.T. Methylene blue analogues: In vitro antimicrobial minimum inhibitory concentrations and in silico pharmacophore modelling. Eur. J. Pharm. Sci. 2021;157:105603. doi: 10.1016/j.ejps.2020.105603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2020.105603</ArticleId><ArticleId IdType="pubmed">33091571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragulat M.R., Abarca M.L., Bruguera M.T., Caba&#xf1;es F.J. Dyes as fungal inhibitors: Effect on colony diameter. Appl. Environ. Microbiol. 1991;57:2777&#x2013;2780. doi: 10.1128/aem.57.9.2777-2780.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aem.57.9.2777-2780.1991</ArticleId><ArticleId IdType="pmc">PMC183658</ArticleId><ArticleId IdType="pubmed">1768153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs E. Prevention of cytopathic effect and propagation of poliovirus by methylene blue. Z. Nat. B. 1960;15:588&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">13831052</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N., Shafran I., Ben-Zvi H., Sofer S., Sheena L., Krause I., Shlomai A., Goldberg E., Sklan E.H. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci. Rep. 2021;11:12703. doi: 10.1038/s41598-021-92220-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92220-0</ArticleId><ArticleId IdType="pmc">PMC8209102</ArticleId><ArticleId IdType="pubmed">34135459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng B.K., Cameron A.J. The role of methylene blue in serotonin syndrome: A systematic review. Psychosomatics. 2010;51:194&#x2013;200. doi: 10.1176/appi.psy.51.3.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.51.3.194</ArticleId><ArticleId IdType="pubmed">20484716</ArticleId></ArticleIdList></Reference><Reference><Citation>Alda M., McKinnon M., Blagdon R., Garnham J., MacLellan S., O&#x2019;Donovan C., Hajek T., Nair C., Dursun S., MacQueen G. Methylene blue treatment for residual symptoms of bipolar disorder: Randomised crossover study. Br. J. Psychiatry. 2017;210:54&#x2013;60. doi: 10.1192/bjp.bp.115.173930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.115.173930</ArticleId><ArticleId IdType="pubmed">27284082</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  FDA Drug Safety Communication: Updated Information about the Drug Interaction Between Methylene Blue (Methylthioninium Chloride) and Serotonergic Psychiatric Medications. FDA.  [(accessed on 15 August 2022)];2011  Available online:  http://www.fda.gov/Drugs/DrugSafety/ucm276119.htm.</Citation></Reference><Reference><Citation>Lu G., Nagbanshi M., Goldau N., Mendes Jorge M., Meissner P., Jahn A., Mockenhaupt F.P., M&#xfc;ller O. Efficacy and safety of methylene blue in the treatment of malaria: A systematic review. BMC Med. 2018;16:59. doi: 10.1186/s12916-018-1045-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-018-1045-3</ArticleId><ArticleId IdType="pmc">PMC5979000</ArticleId><ArticleId IdType="pubmed">29690878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., S&#x103;l&#x103;gean T., Pop I.D., Bordea I.R., Benedicenti S. Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review. J. Inflamm. Res. 2021;14:13&#x2013;56. doi: 10.2147/JIR.S282213.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S282213</ArticleId><ArticleId IdType="pmc">PMC7802346</ArticleId><ArticleId IdType="pubmed">33447071</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4:337&#x2013;361. doi: 10.3934/biophy.2017.3.337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/biophy.2017.3.337</ArticleId><ArticleId IdType="pmc">PMC5523874</ArticleId><ArticleId IdType="pubmed">28748217</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira M.C., Jr., Greiffo F.R., Rigonato-Oliveira N.C., Cust&#xf3;dio R.W., Silva V.R., Damaceno-Rodrigues N.R., Almeida F.M., Albertini R., Lopes-Martins R.&#xc1;., de Oliveira L.V., et al. Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS. J. Photochem. Photobiol. B. 2014;134:57&#x2013;63. doi: 10.1016/j.jphotobiol.2014.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2014.03.021</ArticleId><ArticleId IdType="pubmed">24792475</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima F.M., Villaverde A.B., Albertini R., Corr&#xea;a J.C., Carvalho R.L., Munin E., Ara&#xfa;jo T., Silva J.A., Aimbire F. Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: Action on anti- and pro-inflammatory cytokines. Lasers Surg. Med. 2011;43:410&#x2013;420. doi: 10.1002/lsm.21053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lsm.21053</ArticleId><ArticleId IdType="pubmed">21674546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Bensadoun R.J., Beken S.V., Burton P., Carroll J., Benedicenti S. Outpatient Oral Neuropathic Pain Management with Photobiomodulation Therapy: A Prospective Analgesic Pharmacotherapy-Paralleled Feasibility Trial. Antioxidants. 2022;11:533. doi: 10.3390/antiox11030533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11030533</ArticleId><ArticleId IdType="pmc">PMC8944471</ArticleId><ArticleId IdType="pubmed">35326183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., Bensadoun R.J., Raber-Durlacher J.E., Benedicenti S. Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials. Pharmaceutics. 2021;13:1838. doi: 10.3390/pharmaceutics13111838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13111838</ArticleId><ArticleId IdType="pmc">PMC8624276</ArticleId><ArticleId IdType="pubmed">34834253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., Bensadoun R.J., Benedicenti S. Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials. Antioxidants. 2021;10:1028. doi: 10.3390/antiox10071028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10071028</ArticleId><ArticleId IdType="pmc">PMC8300797</ArticleId><ArticleId IdType="pubmed">34202292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., Benedicenti S., Amaroli A., S&#x103;l&#x103;gean T., Pop I.D., Todea D., Bordea I.R. Photobiomodulation Therapy in Oral Mucositis and Potentially Malignant Oral Lesions: A Therapy Towards the Future. Cancers. 2020;12:1949. doi: 10.3390/cancers12071949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12071949</ArticleId><ArticleId IdType="pmc">PMC7409159</ArticleId><ArticleId IdType="pubmed">32708390</ArticleId></ArticleIdList></Reference><Reference><Citation>Legout&#xe9; F., Bensadoun R.J., Seegers V., Pointreau Y., Caron D., Lang P., Pr&#xe9;vost A., Martin L., Schick U., Morvant B., et al. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: Results of a randomised, triple blind, multicentre phase III trial. Radiat. Oncol. 2019;14:83. doi: 10.1186/s13014-019-1292-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13014-019-1292-2</ArticleId><ArticleId IdType="pmc">PMC6530019</ArticleId><ArticleId IdType="pubmed">31118057</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaroli A., Ferrando S., Hanna R., Gallus L., Benedicenti A., Scarf&#xec; S., Pozzolini M., Benedicenti S. The photobiomodulation effect of higher-fluence 808-nm laser therapy with a flat-top handpiece on the wound healing of the earthworm Dendrobaena veneta: A brief report. Lasers Med. Sci. 2018;33:221&#x2013;225. doi: 10.1007/s10103-016-2132-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-016-2132-3</ArticleId><ArticleId IdType="pubmed">28063017</ArticleId></ArticleIdList></Reference><Reference><Citation>Marashian S.M., Hashemian M., Pourabdollah M., Nasseri M., Mahmoudian S., Reinhart F., Eslaminejad A. Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study. Front. Immunol. 2022;13:929837. doi: 10.3389/fimmu.2022.929837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.929837</ArticleId><ArticleId IdType="pmc">PMC9304695</ArticleId><ArticleId IdType="pubmed">35874678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Guo R., Lei L., Liu H., Wang Y., Wang Y., Qian H., Dai T., Zhang T., Lai Y., et al. Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 2021;109:13&#x2013;22. doi: 10.1002/JLB.4HI0720-470R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4HI0720-470R</ArticleId><ArticleId IdType="pmc">PMC7675546</ArticleId><ArticleId IdType="pubmed">33040384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>de Castro M.S., Miyazawa M., Nogueira E.S.C., Chavasco J.K., Brancaglion G.A., Cerdeiram C.D., Nogueira D.A., Ionta M., Hanemann J.A.C., Brigag&#xe3;o M.R.P.L., et al. Photobiomodulation enhances the Th1 immune response of human monocytes. Lasers Med. Sci. 2022;37:135&#x2013;148. doi: 10.1007/s10103-020-03179-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-020-03179-9</ArticleId><ArticleId IdType="pubmed">33155162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimizuka Y., Katagiri W., Locascio J.J., Shigeta A., Sasaki Y., Shibata M., Morse K., S&#xee;rbulescu R.F., Miyatake M., Reeves P., et al. Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response. J. Immunol. 2018;201:3587&#x2013;3603. doi: 10.4049/jimmunol.1701687.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701687</ArticleId><ArticleId IdType="pmc">PMC6289684</ArticleId><ArticleId IdType="pubmed">30420435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokomizo S., Katagiri W., Maki Y., Sano T., Inoue K., Fukushi M., Atochin D.N., Kushibiki T., Kawana A., Kimizuka Y., et al. Brief exposure of skin to near-infrared laser augments early vaccine responses. Nanophotonics. 2021;10:3187&#x2013;3197. doi: 10.1515/nanoph-2021-0133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/nanoph-2021-0133</ArticleId><ArticleId IdType="pmc">PMC8635068</ArticleId><ArticleId IdType="pubmed">34868804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Dalvi S., Amaroli A., De Angelis N., Benedicenti S. Effects of photobiomodulation on bone defects grafted with bone substitutes: A systematic review of in vivo animal studies. J. Biophotonics. 2021;14:e202000267. doi: 10.1002/jbio.202000267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202000267</ArticleId><ArticleId IdType="pubmed">32857463</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Lan C.E., Yu H.S. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo. Exp. Dermatol. 2019;28:10&#x2013;14. doi: 10.1111/exd.13823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.13823</ArticleId><ArticleId IdType="pubmed">30698884</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan I., Arany P.R. Photobiomodulation Therapy Promotes Expansion of Epithelial Colony Forming Units. Photomed. Laser Surg. 2016;34:550&#x2013;555. doi: 10.1089/pho.2015.4054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/pho.2015.4054</ArticleId><ArticleId IdType="pmc">PMC5116699</ArticleId><ArticleId IdType="pubmed">27841965</ArticleId></ArticleIdList></Reference><Reference><Citation>Oron U., Maltz L., Tuby H., Sorin V., Czerniak A. Enhanced Liver Regeneration Following Acute Hepatectomy by Low-Level Laser Therapy. Photomed. Laser Surg. 2010;28:675&#x2013;678. doi: 10.1089/pho.2009.2756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/pho.2009.2756</ArticleId><ArticleId IdType="pubmed">20932182</ArticleId></ArticleIdList></Reference><Reference><Citation>Oron U. Light therapy and stem cells: A therapeutic intervention of the future? Interv. Cardiol. 2011;3:627&#x2013;629. doi: 10.2217/ica.11.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ica.11.74</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom&#xe9; R.F.F., Silva D.F.B., dos Santos C.A.O., de Vasconcelos G., Almeida Rolim A.K. ILIB (intravascular laser irradiation of blood) as an adjuvant therapy in the treatment of patients with chronic systemic diseases&#x2014;An integrative literature review. Lasers Med. Sci. 2020;35:1899&#x2013;1907. doi: 10.1007/s10103-020-03100-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-020-03100-4</ArticleId><ArticleId IdType="pubmed">32656732</ArticleId></ArticleIdList></Reference><Reference><Citation>Momenzadeh S., Abbasi M., Ebadifar A., Aryani M., Bayrami J., Nematollahi F. The intravenous laser blood irradiation in chronic pain and fibromyalgia. J. Lasers Med. Sci. 2015;6:6&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329142</ArticleId><ArticleId IdType="pubmed">25699161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemikhoo N., Kyavar M., Razzaghi Z., Ansari F., Maleki M., Ghavidel A.A., Gholampour M., Ghaffarinejad M.H. Effects of intravenous and transdermal photobiomodulation on the postoperative complications of coronary artery bypass grafting surgery: A randomized, controlled clinical trial. Lasers Med. Sci. 2021;36:1891&#x2013;1896. doi: 10.1007/s10103-020-03236-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-020-03236-3</ArticleId><ArticleId IdType="pubmed">33398614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiran D.A., Litscher G., Weber M., Ailioaie L.M., Ailioaie C., Litscher D. Intravenous laser blood irradiation increases efficacy of etanercept in selected subtypes of juvenile idiopathic arthritis: An innovative clinical research approach. Evid. Based Complement. Alternat. Med. 2013;2013:168134. doi: 10.1155/2013/168134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/168134</ArticleId><ArticleId IdType="pmc">PMC3749593</ArticleId><ArticleId IdType="pubmed">23990845</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakeeva L., Manteiffel V., Rodichev E., Karu T. Formation of gigantic mitochondria in human blood lymphocytes under the effect of an He-Ne laser. Mol. Biol. Mosk. 1993;27:608&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">8316242</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube A., Hausal, Gupta P.K. Modulation of macrophage structure and function by low level He-Ne irradiation. Photochem. Photobiol. Sci. 2003;2:851&#x2013;855. doi: 10.1039/b301233f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b301233f</ArticleId><ArticleId IdType="pubmed">14521221</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk J., Kruse A., Kirchner H. Cytokine production after helium-neon laser irradiation in cultures of human peripheral blood mononuclear cells. J. Photochem. Photobiol. 1992;16:347&#x2013;355. doi: 10.1016/1011-1344(92)80022-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1011-1344(92)80022-N</ArticleId><ArticleId IdType="pubmed">1479476</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G.Y., Zhao Y.P., Liu T.C.Y., Liu S.H. Membranotropic photobiomodulation on red blood cell deformability, Proc. SPIE 6534; Proceedings of the Fifth International Conference on Photonics and Imaging in Biology and Medicine; Wuhan, China. 1&#x2013;3 September 2006; p. 653424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.741631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna R., Agas D., Benedicenti S., Laus F., Cuteri V., Sabbieti M.G., Amaroli A. A comparative study between the effectiveness of 980nm photobiomodulation, delivered by Gaussian versus flattop profiles on osteoblasts maturation. Front. Endocrinol. 2019;10:92. doi: 10.3389/fendo.2019.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00092</ArticleId><ArticleId IdType="pmc">PMC6391326</ArticleId><ArticleId IdType="pubmed">30842754</ArticleId></ArticleIdList></Reference><Reference><Citation>de Matos B.T.L., Buchaim D.V., Pomini K.T., Barbalho S.M., Guiguer E.L., Reis C.H.B., Bueno C.R.S., Cunha M.R.D., Pereira E.S.B.M., Buchaim R.L. Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review. Life. 2021;11:580. doi: 10.3390/life11060580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11060580</ArticleId><ArticleId IdType="pmc">PMC8233727</ArticleId><ArticleId IdType="pubmed">34207199</ArticleId></ArticleIdList></Reference><Reference><Citation>Walski T., Grzeszczuk-Ku&#x107; K., Ga&#x142;ecka K., Trochanowska-Pauk N., Bohara R., Czerski A., Szu&#x142;drzy&#x144;ski K., Kr&#xf3;likowski W., Detyna J., Komorowska M. Near-infrared photobiomodulation of blood reversibly inhibits platelet reactivity and reduces hemolysis. Sci. Rep. 2022;12:4042. doi: 10.1038/s41598-022-08053-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08053-y</ArticleId><ArticleId IdType="pmc">PMC8904845</ArticleId><ArticleId IdType="pubmed">35260751</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Barrett D.W., Saucedo C.L., O&#x2019;Connor P., Liu H., Gonzalez-Lima F. Cognitive Enhancement by Transcranial Photobiomodulation Is Associated With Cerebrovascular Oxygenation of the Prefrontal Cortex. Front. Neurosci. 2019;13:1129. doi: 10.3389/fnins.2019.01129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01129</ArticleId><ArticleId IdType="pmc">PMC6813459</ArticleId><ArticleId IdType="pubmed">31680847</ArticleId></ArticleIdList></Reference><Reference><Citation>Murilo X., Oliveira M.X., Toma R.L., Jones B.J.L., Cyprien T.P., Tier M.R., Wallace C.A., Renno A.C.M., Sabapathy S., Laakso S.E.L. Effects of photobiomodulation therapy (pulsed LASER 904 nm) on muscle oxygenation and performance in exercise-induced skeletal muscle fatigue in young women: A pilot study; Proceedings of the Mechanisms of Photobiomodulation Therapy XII; San Francisco, CA, USA. 28 January&#x2013;2 February 2017; p. 100480J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.2253585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruitt T., Carter C., Wang X., Wu A., Liu H. Photobiomodulation at Different Wavelengths Boosts Mitochondrial Redox Metabolism and Hemoglobin Oxygenation: Lasers vs. Light-Emitting Diodes In Vivo. Metabolites. 2022;12:103. doi: 10.3390/metabo12020103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12020103</ArticleId><ArticleId IdType="pmc">PMC8880116</ArticleId><ArticleId IdType="pubmed">35208178</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares S.N., Beltrame T., Ferraresi C., Galdino G.A.M., Catai A.M. Photobiomodulation effect on local hemoglobin concentration assessed by near-infrared spectroscopy in humans. Lasers Med. Sci. 2020;35:641&#x2013;649. doi: 10.1007/s10103-019-02861-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-019-02861-x</ArticleId><ArticleId IdType="pubmed">31420794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen L.C., Berman M., Halper J., Chazot P. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70. Int. J. Mol. Sci. 2022;23:5221. doi: 10.3390/ijms23095221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23095221</ArticleId><ArticleId IdType="pmc">PMC9105035</ArticleId><ArticleId IdType="pubmed">35563611</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehpour F., Gholipour-Khalili S., Farajdokht F., Kamari F., Walski T., Hamblin M.R., DiDuro J.O., Cassano P. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: A narrative review. Rev. Neurosci. 2020;31:269&#x2013;286. doi: 10.1515/revneuro-2019-0063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2019-0063</ArticleId><ArticleId IdType="pmc">PMC7138738</ArticleId><ArticleId IdType="pubmed">31812948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ailioaie L.M., Litscher G., Weber M., Ailioaie C., Litscher D., Chiran A.D. Innovations and Challenges by Applying Sublingual Laser Blood Irradiation in Juvenile Idiopathic Arthritis. Int. J. Photoenergy. 2014;2014:130417. doi: 10.1155/2014/130417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/130417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalvi S., Benedicenti S., Hanna R. Is antimicrobial photodynamic therapy an effective treatment modality for aggressive periodontitis? A systematic review of in vivo human randomized controlled clinical trials. Photodiag. Photodyn. Ther. 2021;34:102314. doi: 10.1016/j.pdpdt.2021.102314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2021.102314</ArticleId><ArticleId IdType="pubmed">33932563</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalvi S., Benedicenti S., S&#x103;l&#x103;gean T., Bordea I.R., Hanna R. Effectiveness of Antimicrobial Photodynamic Therapy in the Treatment of Periodontitis: A Systematic Review and Meta-Analysis of In Vivo Human Randomized Controlled Clinical Trials. Pharmaceutics. 2021;13:836. doi: 10.3390/pharmaceutics13060836.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13060836</ArticleId><ArticleId IdType="pmc">PMC8228221</ArticleId><ArticleId IdType="pubmed">34200078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalvi S.A., Hanna R., Gattani D.R. Utilisation of antimicrobial photodynamic therapy as an adjunctive tool for open flap debridement in the management of chronic periodontitis: A randomized controlled clinical trial. Photodiagnosis Photodyn. Ther. 2019;25:440&#x2013;447. doi: 10.1016/j.pdpdt.2019.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2019.01.023</ArticleId><ArticleId IdType="pubmed">30684674</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R., Hamblin M.R. Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight. Curr. Med. Chem. 2015;22:2159&#x2013;2185. doi: 10.2174/0929867322666150319120134.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867322666150319120134</ArticleId><ArticleId IdType="pubmed">25787964</ArticleId></ArticleIdList></Reference><Reference><Citation>Voos A.C., Kranz S., Tonndorf-Martini S., Voelpel A., Sigusch H., Staudte H., Albrecht V., Sigusch B.W. Photodynamic antimicrobial effect of safranine O on an ex vivo periodontal biofilm. Lasers Surg. Med. 2014;46:235&#x2013;243. doi: 10.1002/lsm.22217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lsm.22217</ArticleId><ArticleId IdType="pubmed">24473989</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannelli M., Bani D. Appropriate laser wavelengths for photodynamic therapy with methylene blue. Lasers Med. Sci. 2018;33:1837&#x2013;1838. doi: 10.1007/s10103-018-2566-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-018-2566-x</ArticleId><ArticleId IdType="pubmed">29959632</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider J.E., Jr., Tabatabaie T., Maidt L., Smith R.H., Nguyen X., Pye Q., Floyd R.A. Potential mechanisms of photodynamic inactivation of virus by methylene blue. I. RNA-protein crosslinks and other oxidative lesions in Q beta bacteriophage. Photochem. Photobiol. 1998;67:350&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">9523535</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe H., Wagnerm S.J. Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization. Photochem. Photobiol. 1995;61:402&#x2013;409. doi: 10.1111/j.1751-1097.1995.tb08630.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-1097.1995.tb08630.x</ArticleId><ArticleId IdType="pubmed">7740085</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann B.K.-H.J.B., Lambrecht B., Mohr H. Target structures for HIV-1 inactivation by methylene blue and light. J. Med. Virol. 1995;47:172&#x2013;178. doi: 10.1002/jmv.1890470211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890470211</ArticleId><ArticleId IdType="pubmed">8830122</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedigo L.A., Gibbs A.J., Scott R.J., Street C.N. Absence of Bacterial Resistance Following Repeat Exposure to Photodynamic Therapy, Proceedings of the Photodynamic Therapy: Back to the Future. SPIE; Bellingham, WA, USA: 2009. p. 73803H.</Citation></Reference><Reference><Citation>Duguay B.A., Herod A., Pringle E.S., Monro S.M.A., Hetu M., Cameron C.G., McFarland S.A., McCormick C. Photodynamic Inactivation of Human Coronaviruses. Viruses. 2022;14:110. doi: 10.3390/v14010110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010110</ArticleId><ArticleId IdType="pmc">PMC8779093</ArticleId><ArticleId IdType="pubmed">35062314</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L., Faustino M.A., Neves M.G., Cunha A., Almeida A. Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses. 2012;4:1034&#x2013;1074. doi: 10.3390/v4071034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4071034</ArticleId><ArticleId IdType="pmc">PMC3407894</ArticleId><ArticleId IdType="pubmed">22852040</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustanti L., Hobson-Peters J., Colmant A.M.G., Hall R.A., Young P.R., Reichenberg S., Tolksdorf F., Sumian C., Gravemann U., Seltsam A.M., et al. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light. Transfusion. 2020;60:2655&#x2013;2660. doi: 10.1111/trf.16021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16021</ArticleId><ArticleId IdType="pubmed">32830340</ArticleId></ArticleIdList></Reference><Reference><Citation>Eickmann M., Gravemann U., Handke W., Tolksdorf F., Reichenberg S., Muller T.H., Seltsam A. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively. Transfusion. 2018;58:2202&#x2013;2207. doi: 10.1111/trf.14652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.14652</ArticleId><ArticleId IdType="pmc">PMC7169708</ArticleId><ArticleId IdType="pubmed">29732571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr H., Knuver-Hopf J., Gravemann U., Redecker-Klein A., Muller T.H. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion. 2004;44:886&#x2013;890. doi: 10.1111/j.1537-2995.2004.03424.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2004.03424.x</ArticleId><ArticleId IdType="pubmed">15157256</ArticleId></ArticleIdList></Reference><Reference><Citation>Papin J.F., Floyd R.A., Dittmer D.P. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo. Antivir. Res. 2005;68:84&#x2013;87. doi: 10.1016/j.antiviral.2005.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.07.001</ArticleId><ArticleId IdType="pubmed">16118025</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Wei Q., Alvarez X., Wang H., Du Y., Zhu H., Jiang H., Zhou J., Lam P., Zhang L., et al. Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques. J. Virol. 2011;85:4025&#x2013;4030. doi: 10.1128/JVI.02292-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02292-10</ArticleId><ArticleId IdType="pmc">PMC3126125</ArticleId><ArticleId IdType="pubmed">21289121</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N., P&#xe9;rez P., Kato T., Mikami Y., Okuda K., Gilmore R.C., Conde C.D., Gasmi B., Stein S., Beach M., et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat. Med. 2021;27:892&#x2013;903. doi: 10.1038/s41591-021-01296-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01296-8</ArticleId><ArticleId IdType="pmc">PMC8240394</ArticleId><ArticleId IdType="pubmed">33767405</ArticleId></ArticleIdList></Reference><Reference><Citation>Woelfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Mueller M.A., Niemeyer D., Jones Kelly T.C., Vollmar P., Rothe C., et al. Virological assessment of hospitalized cases of coronavirus disease 2019. MedRxiv. 2020 doi: 10.1101/2020.03.05.20030502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.05.20030502</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Schikora D., Hepburn J., Plavin S.R. Reduction of the Viral Load by Non-Invasive Photodynamic Therapy in Early Stages of COVID-19 infection. Am. J. Virol. Dis. 2020;2:1&#x2013;5.</Citation></Reference><Reference><Citation>Soria M.E., Cort&#xf3;n M., Mart&#xed;nez-Gonz&#xe1;lez B., Lobo-Vega R., V&#xe1;zquez-Sirvent L., L&#xf3;pez-Rodr&#xed;guez R., Almoguera B., Mahillo I., M&#xed;nguez P., Herrero A., et al. High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease. Access Microbiol. 2021;3:000259. doi: 10.1099/acmi.0.000259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/acmi.0.000259</ArticleId><ArticleId IdType="pmc">PMC8549390</ArticleId><ArticleId IdType="pubmed">34712904</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniell H., Nair S.K., Esmaeili N., Wakade G., Shahid N., Ganesan P.K., Islam M.R., Shepley-McTaggart A., Feng S., Gary E.N., et al. Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection. Mol. Ther. 2022;30:1966&#x2013;1978. doi: 10.1016/j.ymthe.2021.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.11.008</ArticleId><ArticleId IdType="pmc">PMC8580552</ArticleId><ArticleId IdType="pubmed">34774754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mroz P., Szokalska A., Wu M.X., Hamblin M.R. Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response. PLoS ONE. 2010;5:e15194. doi: 10.1371/journal.pone.0015194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015194</ArticleId><ArticleId IdType="pmc">PMC3001867</ArticleId><ArticleId IdType="pubmed">21179470</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tanaka M., Vecchio D., Garcia-Diaz M., Chang J., Morimoto Y., Hamblin M.R. Photodynamic Therapy Induces an Immune Response Against a Bacterial Pathogen. Expert Rev. Clin. Immunol. 2012;8:479&#x2013;494. doi: 10.1586/eci.12.37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.12.37</ArticleId><ArticleId IdType="pmc">PMC3506647</ArticleId><ArticleId IdType="pubmed">22882222</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M.H., Mehran Y.Z., Orthaber A., Saadat H.H., Robert Weber R., Wojcik M. Successful Reduction of SARS-CoV-2 Viral Load by Photodynamic Therapy (PDT) Verified by QPCR&#x2014;A Novel Approach in Treating Patients in Early Infection Stages. Med. Clin. Res. 2020;5:311&#x2013;325.</Citation></Reference><Reference><Citation>Collins L.M., Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 1987;66:1300&#x2013;1302. doi: 10.1177/00220345870660080201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00220345870660080201</ArticleId><ArticleId IdType="pubmed">3476596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardivo J.P., Del Giglio A., de Oliveira C.S., Gabrielli D.S., Junqueira H.C., Tada D.B., Severino D., de F&#xe1;tima Turchiello R., Baptista M.S. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagnosis Photodyn. Ther. 2005;2:175&#x2013;191. doi: 10.1016/S1572-1000(05)00097-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1572-1000(05)00097-9</ArticleId><ArticleId IdType="pubmed">25048768</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.Y., Chen A.C., Carroll J.D., Hamblin M.R. Biphasic dose response in low level light therapy. Dose Response. 2009;7:58&#x2013;83. doi: 10.2203/dose-response.09-027.Hamblin.</Citation><ArticleIdList><ArticleId IdType="doi">10.2203/dose-response.09-027.Hamblin</ArticleId><ArticleId IdType="pmc">PMC2790317</ArticleId><ArticleId IdType="pubmed">20011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Winchester L.W., Chou N.Y. Measurement of sublingual blood velocity as a tool for monitoring sepsis. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2008;2008:3739&#x2013;3742. doi: 10.1109/IEMBS.2008.4650021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/IEMBS.2008.4650021</ArticleId><ArticleId IdType="pmc">PMC2784996</ArticleId><ArticleId IdType="pubmed">19163524</ArticleId></ArticleIdList></Reference><Reference><Citation>Research and Statistics Department Ministry of Tourism Bahamas. 2019.  [(accessed on 15 August 2022)].  Available online:  http://www.tourismtoday.com/sites/default/fles/freequently_requested_statistics_brochure_2019_latest_1.pdf.</Citation></Reference><Reference><Citation>Walter-Sack I., Rengelshausen J., Oberwittler H., Burhenne J., Mueller O., Meissner P., Mikus G. High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur. J. Clin. Pharmacol. 2009;65:179&#x2013;189. doi: 10.1007/s00228-008-0563-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-008-0563-x</ArticleId><ArticleId IdType="pubmed">18810398</ArticleId></ArticleIdList></Reference><Reference><Citation>Grauman Neander N., Loner C.A., Rotoli J.M. The Acute Treatment of Methemoglobinemia in Pregnancy. J. Emerg. Med. 2018;54:685&#x2013;689. doi: 10.1016/j.jemermed.2018.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2018.01.038</ArticleId><ArticleId IdType="pubmed">29627348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo C.S., Rodrigues-Santos P., Pereira D., N&#xfa;nez J., Tr&#xea;pa J.C.D., Sousa D.L., Louren&#xe7;o J.V., Coelho M.F., de Almeida L.P., da Cunha J.S., et al. Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation. Photochem. Photobiol. Sci. 2022;21:1101&#x2013;1109. doi: 10.1007/s43630-022-00202-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43630-022-00202-6</ArticleId><ArticleId IdType="pmc">PMC8933164</ArticleId><ArticleId IdType="pubmed">35304729</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari D.H., Moghaddam A.B., Amini S., Keramati M.R., Zarmehri A.M., Alamdari A.H., Damsaz M., Banpour H., Yarahmadi A., Koliakos G. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur. J. Pharmacol. 2020;885:173494. doi: 10.1016/j.ejphar.2020.173494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173494</ArticleId><ArticleId IdType="pmc">PMC7440159</ArticleId><ArticleId IdType="pubmed">32828741</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari D.H., Hafizi-Lotfabadi S., Bagheri-Moghaddam A., Safari H., Mozdourian M., Javidarabshahi Z., Peivandi-Yazdi A., Ali-Zeraati A., Sedaghat A., Poursadegh F., et al. Methylene Blue for Treatment of Hospitalized COVID-19 Patients: A Randomized, Controlled, Open-Label, Clinical Trial, Phase 2. Rev. Invest. Clin. 2021;73:190&#x2013;198. doi: 10.24875/RIC.21000028.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/RIC.21000028</ArticleId><ArticleId IdType="pubmed">34019535</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari D.H., Lotfabadi S.H., Darban B.M., Agheli-Rad M., Saadatian S., Hashemi S.H., Ahmasabadi F.B., Morovatdar N., Arastoo M., Bhushan B. Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3. Aristotle Biomed. J. 2021;3:12&#x2013;18.</Citation></Reference><Reference><Citation>Sigman S.A., Mokmeli S., Monici M., Vetrici M.A. A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19. Am. J. Case Rep. 2020;21:e926779. doi: 10.12659/AJCR.926779.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.926779</ArticleId><ArticleId IdType="pmc">PMC7449510</ArticleId><ArticleId IdType="pubmed">32865522</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams R.K., Raimondo J., Cahn D., Williams A., Schell D. Whole-organ transdermal photobiomodulation (PBM) of COVID-19: A 50-patient case study. J. Biophotonics. 2022;15:e202100194. doi: 10.1002/jbio.202100194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202100194</ArticleId><ArticleId IdType="pmc">PMC8646787</ArticleId><ArticleId IdType="pubmed">34658147</ArticleId></ArticleIdList></Reference><Reference><Citation>Aroso R.T., Piccirillo G., Arnaut Z.A., Gonzalez A.C.S., Rodrigues F.M.S., Pereira M.M. Photodynamic inactivation of influenza virus as a potential alternative for the control of respiratory tract infection. J. Photochem. Photobiol. 2021;7:100043.</Citation></Reference><Reference><Citation>Schagen F.H., Moor A.C., Cheong S.C., Cramer S.J., van Ormondt H., van der Eb A.J., Dubbelman T.M., Hoeben R.C. Photodynamic treatment of adenoviral vectors with visible light: An easy and convenient method for viral inactivation. Gene Ther. 1999;6:873&#x2013;881. doi: 10.1038/sj.gt.3300897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gt.3300897</ArticleId><ArticleId IdType="pubmed">10505113</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L., Burgado J., Baker-Wagner M., Kitaygorodskyy A., Olson V., Lingappa V.R., Satheshkumar P.S. New methylene blue derivatives suggest novel anti-orthopoxviral strategies. Antivir. Res. 2021;191:105086. doi: 10.1016/j.antiviral.2021.105086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2021.105086</ArticleId><ArticleId IdType="pmc">PMC9629033</ArticleId><ArticleId IdType="pubmed">33992710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>